-
Je něco špatně v tomto záznamu ?
Clinical Potential of Effective Noninvasive Exclusion of KEL1-Positive Fetuses in KEL1-Negative Pregnant Women
J. Böhmova, R. Vodicka, M. Lubusky, I. Holuskova, M. Studnickova, R. Kratochvilova, E. Krejcirikova, M. Janikova, V. Durdová, T. Dolezalová, H. Filipová, L. Dusek, I. Dhaifalah, K. Vomackova, M. Kacerovsky, M. Prochazka, R. Vrtel,
Jazyk angličtina Země Švýcarsko
Typ dokumentu časopisecké články
Grantová podpora
NT12225
MZ0
CEP - Centrální evidence projektů
PubMed
26492079
DOI
10.1159/000441296
Knihovny.cz E-zdroje
- MeSH
- antigeny krevních skupin genetika MeSH
- dospělí MeSH
- falešně negativní reakce MeSH
- falešně pozitivní reakce MeSH
- genotypizační techniky * MeSH
- hemolytická nemoc plodu a novorozence diagnóza MeSH
- lidé MeSH
- membránové glykoproteiny genetika MeSH
- metaloendopeptidasy genetika MeSH
- plod * MeSH
- senzitivita a specificita MeSH
- těhotenství MeSH
- Check Tag
- dospělí MeSH
- lidé MeSH
- těhotenství MeSH
- ženské pohlaví MeSH
- Publikační typ
- časopisecké články MeSH
BACKGROUND: The clinical importance of assessing the fetal KEL genotype is to exclude 'K'-positive fetuses (genotype KEL1/KEL2) in 'K'-alloimmunized pregnant women (genotype KEL2/KEL2). Noninvasive assessment of the fetal KEL genotype is not yet available in the Czech Republic. OBJECTIVE: The aim of this study was to assess the fetal KEL1/KEL2 genotype from cell-free fetal DNA in the plasma of KEL2/KEL2 pregnant women. METHODS: The fetal genotype was assessed by minisequencing (a dilution series including control samples). A total of 138 pregnant women (between the 8th and 23rd gestational week) were tested by minisequencing. The fetal genotype was further verified by analysis of a buccal swab from the newborn. RESULTS: Minisequencing proved to be a reliable method. In 2.2% (3/138) of the examined women, plasma sample testing failed; 94.8% (128/135) had the KEL2/KEL2 genotype, and a total of 3.1% of fetuses (4/128) had the KEL1/KEL2 genotype. Sensitivity and specificity reached 100% (p < 0.0001). CONCLUSION: Minisequencing is a reliable method for the assessment of the fetal KEL1 allele from the plasma of KEL2/KEL2 pregnant women.
Masaryk University Institute of Biostatistics and Analyses Brno
University Hospital and Palacky University Olomouc Olomouc Czech Republic
Univesity Hospital Hradec Kralove Hradec Králové Czech republic
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc17014238
- 003
- CZ-PrNML
- 005
- 20181009101418.0
- 007
- ta
- 008
- 170413s2016 sz f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1159/000441296 $2 doi
- 035 __
- $a (PubMed)26492079
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a sz
- 100 1_
- $a Böhmová, Jana $u University Hospital and Palacky University Olomouc, Olomouc, Czech Republic $7 xx0169229
- 245 10
- $a Clinical Potential of Effective Noninvasive Exclusion of KEL1-Positive Fetuses in KEL1-Negative Pregnant Women / $c J. Böhmova, R. Vodicka, M. Lubusky, I. Holuskova, M. Studnickova, R. Kratochvilova, E. Krejcirikova, M. Janikova, V. Durdová, T. Dolezalová, H. Filipová, L. Dusek, I. Dhaifalah, K. Vomackova, M. Kacerovsky, M. Prochazka, R. Vrtel,
- 520 9_
- $a BACKGROUND: The clinical importance of assessing the fetal KEL genotype is to exclude 'K'-positive fetuses (genotype KEL1/KEL2) in 'K'-alloimmunized pregnant women (genotype KEL2/KEL2). Noninvasive assessment of the fetal KEL genotype is not yet available in the Czech Republic. OBJECTIVE: The aim of this study was to assess the fetal KEL1/KEL2 genotype from cell-free fetal DNA in the plasma of KEL2/KEL2 pregnant women. METHODS: The fetal genotype was assessed by minisequencing (a dilution series including control samples). A total of 138 pregnant women (between the 8th and 23rd gestational week) were tested by minisequencing. The fetal genotype was further verified by analysis of a buccal swab from the newborn. RESULTS: Minisequencing proved to be a reliable method. In 2.2% (3/138) of the examined women, plasma sample testing failed; 94.8% (128/135) had the KEL2/KEL2 genotype, and a total of 3.1% of fetuses (4/128) had the KEL1/KEL2 genotype. Sensitivity and specificity reached 100% (p < 0.0001). CONCLUSION: Minisequencing is a reliable method for the assessment of the fetal KEL1 allele from the plasma of KEL2/KEL2 pregnant women.
- 650 _2
- $a dospělí $7 D000328
- 650 _2
- $a antigeny krevních skupin $x genetika $7 D001789
- 650 _2
- $a hemolytická nemoc plodu a novorozence $x diagnóza $7 D004899
- 650 _2
- $a falešně negativní reakce $7 D005188
- 650 _2
- $a falešně pozitivní reakce $7 D005189
- 650 _2
- $a ženské pohlaví $7 D005260
- 650 12
- $a plod $7 D005333
- 650 12
- $a genotypizační techniky $7 D060005
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a membránové glykoproteiny $x genetika $7 D008562
- 650 _2
- $a metaloendopeptidasy $x genetika $7 D008666
- 650 _2
- $a těhotenství $7 D011247
- 650 _2
- $a senzitivita a specificita $7 D012680
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Vodička, Radek $7 xx0019317 $u University Hospital and Palacky University Olomouc, Olomouc, Czech Republic
- 700 1_
- $a Ľubušký, Marek, $d 1970- $7 xx0073925 $u University Hospital and Palacky University Olomouc, Olomouc, Czech Republic
- 700 1_
- $a Holusková, Iva $7 xx0169232 $u University Hospital and Palacky University Olomouc, Olomouc, Czech Republic
- 700 1_
- $a Studničková, Martina $7 xx0143719 $u University Hospital and Palacky University Olomouc, Olomouc, Czech Republic
- 700 1_
- $a Kratochvílová, Romana $7 xx0169233 $u University Hospital and Palacky University Olomouc, Olomouc, Czech Republic
- 700 1_
- $a Krejčiříková, Eva $7 xx0107105 $u University Hospital and Palacky University Olomouc, Olomouc, Czech Republic
- 700 1_
- $a Janíková, Mária $7 xx0267892 $u University Hospital and Palacky University Olomouc, Olomouc, Czech Republic
- 700 1_
- $a Durdová, Veronika $7 xx0257402 $u University Hospital and Palacky University Olomouc, Olomouc, Czech Republic
- 700 1_
- $a Dolezalová, Tereza $u University Hospital and Palacky University Olomouc, Olomouc, Czech Republic
- 700 1_
- $a Filipová, Hana $7 xx0169230 $u University Hospital and Palacky University Olomouc, Olomouc, Czech Republic
- 700 1_
- $a Dušek, Ladislav, $d 1967- $7 mzk2003181727 $u Masaryk University Institute of Biostatistics and Analyses Brno
- 700 1_
- $a Dhaifalah, Ishraq A., $d 1964- $7 xx0018900 $u University Hospital and Palacky University Olomouc, Olomouc, Czech Republic
- 700 1_
- $a Vomáčková, Katherine $7 xx0142837 $u University Hospital and Palacky University Olomouc, Olomouc, Czech Republic
- 700 1_
- $a Kacerovsky, Marian $u Univesity Hospital Hradec Kralove, Hradec Králové, Czech republic
- 700 1_
- $a Procházka, Martin, $d 1970- $7 xx0019288 $u University Hospital and Palacky University Olomouc, Olomouc, Czech Republic
- 700 1_
- $a Vrtěl, Radek $7 xx0060360 $u University Hospital and Palacky University Olomouc, Olomouc, Czech Republic
- 773 0_
- $w MED00001797 $t Fetal diagnosis and therapy $x 1421-9964 $g Roč. 40, č. 1 (2016), s. 48-53
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/26492079 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20170413 $b ABA008
- 991 __
- $a 20181009101906 $b ABA008
- 999 __
- $a ok $b bmc $g 1200703 $s 975016
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2016 $b 40 $c 1 $d 48-53 $e 20151023 $i 1421-9964 $m Fetal diagnosis and therapy $n Fetal Diagn Ther $x MED00001797
- GRA __
- $a NT12225 $p MZ0
- LZP __
- $a Pubmed-20170413